MOTS-c (mitochondrial-derived peptide, exercise-mimetic) vs ADM5 (Adropin/Adropin-related metabolic peptide): How They Compare

In the realm of peptide research, MOTS-c and ADM5 are two compounds that have been studied for their roles in metabolic regulation. MOTS-c, a mitochondrial-derived peptide with exercise-mimetic properties, and ADM5, also known as Adropin, are both implicated in energy metabolism and glucose homeostasis. This comparison aims to provide an overview of their respective classes, mechanisms, and potential applications based on the available scientific literature.

Mechanism of Action

MOTS-c is a mitochondrial-derived peptide that exhibits exercise-mimetic effects by activating AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) ^[37]. This activation leads to improved glucose metabolism, increased fatty acid oxidation, and enhanced mitochondrial biogenesis. In contrast, the mechanism of ADM5 is not detailed in the provided source material, although it is known to be a peptide hormone involved in the regulation of energy metabolism and glucose homeostasis ^[48].

Primary Use and Benefits

MOTS-c has shown potential benefits in preclinical models for individuals with type 2 diabetes or insulin resistance by improving insulin sensitivity and glucose tolerance ^[37]. It may also have applications in weight management and promoting a more oxidative metabolic phenotype. ADM5, on the other hand, is implicated in the pathophysiology of obesity, type 2 diabetes, and other metabolic disorders ^[48], suggesting its potential role in metabolic regulation.

Administration and Safety

The typical injectable protocol for MOTS-c is not well-established due to its experimental nature, and the safety profile and potential side effects are not fully established ^[37]. Similarly, the typical injectable protocol and safety profile for ADM5 are not detailed in the provided source material. It is important to note that further research is needed to establish the safety and efficacy of both peptides.

Evidence Strength

The evidence supporting the benefits of MOTS-c comes from preclinical models that demonstrate improved insulin sensitivity and glucose tolerance ^[37]. For ADM5, its role in metabolic regulation is supported by its implication in the pathophysiology of metabolic disorders ^[48]. Both peptides require further clinical research to confirm their therapeutic potential and safety.

References

1. Cosmetic Dermatology_ Products and Procedures
2. Endocrinology_ Adult and Pediatric
3. GPCRs_ From Deorphanization to Lead Structure Identification
4. Handbook of Biologically Active Peptides
5. Hypothalamic Integration of Energy Metabolism
6. Kosmetik für Ärzte und Apotheker
7. Life Force
8. Living a Fully Optimized Life
9. Mechanisms of Photoaging and Cutaneous Photocarcinogenesis
10. Peptide Protocols Volume One — William A Seeds MD
11. Peptide Therapeutics_ Design and Development
12. Peptide and Protein Design for Biopharmaceutical Applications
13. Peptides_ Chemistry and Biology, 2nd Edition
14. Pharmacology
15. Photoimmunology of Langerhans cells
16. The Perricone Prescription
17. The Pineal and its Hormones
18. Therapeutic Peptides and Proteins Formulation, Processing — Ajay K Banga
19. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
20. α-MSH related peptides_ a new class of anti-inflammatory and immunomodulating drugs

📚 The 4,000+ sources behind PeptideXR →